• Polyphyllin I Induces Ferroptosis via Nrf2/HO-1/GPX4 in HCC

  2026-07-13

  A recent study demonstrates that Polyphyllin I, a natural compound from Paris polyphylla, induces ferroptosis and mitochondrial dysfunction in hepatocellular carcinoma (HCC) cells through modulation of the Nrf2/HO-1/GPX4 axis. These findings clarify the molecular mechanisms underlying Polyphyllin I's antitumor activity and suggest promising therapeutic strategies for HCC.

• APOC1 Targeting and Cyclopamine Synergy in Thyroid Carcinoma

  2026-07-13

  This study identifies Apolipoprotein C1 (APOC1) as a novel driver of papillary thyroid carcinoma (PTC) progression and immune evasion. By integrating bioinformatics, cell-based assays, and animal models, the authors demonstrate that cyclopamine—a Hedgehog signaling inhibitor—not only suppresses PTC cell growth but also acts synergistically when APOC1 is depleted, providing a rationale for combinatorial therapeutic strategies.

• CRISPR/dCas9-Driven Demethylation of BRD7 Suppresses NPC Pro

  2026-07-12

  This study demonstrates that targeted demethylation of the BRD7 promoter using a CRISPR/dCas9-TET1CD system restores BRD7 expression and inhibits malignant progression in nasopharyngeal carcinoma (NPC). The findings clarify the epigenetic mechanism behind BRD7 silencing and provide a precise tool for tumor suppressor gene reactivation.

• Carboplatin in 3D Cancer Models: Redefining In Vitro Oncolog

  2026-07-10

  Explore how Carboplatin, a platinum-based DNA synthesis inhibitor, reveals new insights in preclinical oncology research through advanced 3D cell models. This article uncovers unique proteomic responses, practical assay guidance, and strategic differentiation from conventional studies.

• Go 6983: Pan-PKC Inhibition for Translational Neurobehaviora

  2026-07-09

  Explore how Go 6983, a potent pan-PKC inhibitor, enables translational researchers to dissect PKC-dependent mechanisms in neurodevelopmental disorders and cancer biology. This thought-leadership article bridges mechanistic insight with actionable guidance, leveraging recent evidence on PKC’s role in autism spectrum disorder and offering practical parameters for robust, reproducible PKC signaling pathway research. Learn how APExBIO’s Go 6983 elevates experimental rigor and opens new frontiers in cell fate and behavior studies.

• Ionomycin Calcium Salt: Precision Calcium Ionophore for Cell

  2026-07-09

  Ionomycin calcium salt enables robust, reproducible control of intracellular Ca2+—fueling advanced studies in cancer biology and calcium signaling. Leverage APExBIO’s trusted reagent for streamlined workflows, precise apoptosis induction, and superior modulation of cell fate in vitro and in vivo.

• Applied Workflows with Influenza Hemagglutinin (HA) Peptide

  2026-07-08

  The Influenza Hemagglutinin (HA) Peptide enables high-fidelity detection, purification, and elution of HA-tagged proteins for advanced molecular biology. This article delivers actionable workflows, troubleshooting strategies, and a direct link to the latest research on protein autopalmitoylation. See how APExBIO’s high-purity HA tag peptide accelerates discovery across proteomics and cancer biology.

• A40926: Potent Dalbavancin Precursor for Gram-Positive Resea

  2026-07-08

  A40926, a natural glycopeptide antibiotic and direct dalbavancin precursor, exhibits potent and selective inhibition of Gram-positive bacteria and Neisseria gonorrhoeae. Its efficacy, precise mechanism, and robust assay performance make it a cornerstone for bacterial cell wall synthesis research and resistant pathogen studies.

• Haloprogin: Broad-Spectrum Topical Antifungal Mechanisms

  2026-07-07

  The seminal 1970 study rigorously characterized Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a potent topical agent with dual antifungal and selective antibacterial effects. Its evidence-backed efficacy against dermatophytes, Candida, and Gram-positive bacteria informs ongoing research in topical antimicrobial development.

• FLT3-TAZ Signaling Drives Drug Resistance in BP-CML: Insight

  2026-07-07

  Shin et al. reposition FLT3 as a key driver of drug resistance in blast phase chronic myeloid leukemia (BP-CML), uncovering a FLT3-JAK-STAT3-TAZ-TEAD-CD36 axis that predicts poor prognosis and provides a new therapeutic target. Their integrated multi-omics and patient sample approach reveals that targeting FLT3 can overcome resistance to BCR::ABL1 tyrosine kinase inhibitors, guiding future translational research.

• Anti Reverse Cap Analog (ARCA): Precision mRNA Capping in Ne

  2026-07-06

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, enables ultra-efficient, orientation-specific mRNA capping for advanced synthetic biology and mRNA therapeutics research. This article uniquely dissects ARCA’s protocol nuances and metabolic implications, providing a deeper, actionable perspective for experimental planning.

• Guilu Erxian Glue Mitigates Oxidative Damage via Keap1/Nrf2

  2026-07-06

  This study demonstrates that Guilu Erxian glue (GLEXG) reduces oxidative injury in mouse GC-1 spermatogonial cells by modulating autophagy through the Keap1/Nrf2 pathway. The findings offer mechanistic insight into how traditional Chinese medicine can protect male germ cells from oxidative stress, informing future research on male infertility and cellular stress responses.

• Purmorphamine as a Smoothened Agonist: Applied Workflows & T

  2026-07-05

  Purmorphamine is redefining Hedgehog pathway research as a potent Smoothened agonist, enabling precise control over osteoblast differentiation and neural signaling studies. This guide translates the latest experimental insights—including insect model breakthroughs—into actionable workflows, troubleshooting strategies, and advanced assay design.

• Foretinib (GSK1363089): Redefining Multikinase Cancer Resear

  2026-07-04

  This article explores how Foretinib (GSK1363089), a potent ATP-competitive multikinase inhibitor, is transforming translational cancer research. By integrating mechanistic insights, experimental best practices, and strategic guidance, we offer a comprehensive framework for deploying Foretinib in advanced oncology models, bridging the gap between in vitro findings and translational impact.

• Pentoxifylline: Applied Protocols for Inflammation Research

  2026-07-03

  Pentoxifylline stands out as a versatile phosphodiesterase inhibitor, enabling precise modulation of inflammatory pathways across cell and animal models. This article translates recent advances—including innovative niosome delivery for psoriasis—into actionable workflows and troubleshooting strategies for immunology and pharmacology labs.

16384 records 1/1093 page Next 12345 下5页 Last page